JWH-147
JWH-147 is an analgesic drug used in scientific research, which acts as a cannabinoid agonist at both the CB 1 and CB 2 receptors.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
JWH-147 is an analgesic drug used in scientific research, which acts as a cannabinoid agonist at both the CB 1 and CB 2 receptors. It is somewhat selective for the CB 2 subtype, with a K i of 11.0 nM at CB 1 vs 7.1 nM at CB 2 . It was discovered and named after the renowned professor of organic chemistry John W. Huffman.
JWH-147 is an analgesic drug used in scientific research, which acts as a cannabinoid agonist at both the CB 1 and CB 2 receptors. It is somewhat selective for the CB 2 subtype, with a K i of 11.0 nM at CB 1 vs 7.1 nM at CB 2 . It was discovered and named after the renowned professor of organic chemistry John W. Huffman.
Legal status
In the United States, CB 1 receptor agonists of the 3-(1-naphthoyl)pyrrole class such as JWH-147 are Schedule I Controlled Substances. JWH-147 was banned in Sweden on 1 October 2010 as harmful to health, after being identified as an ingredient in "herbal" synthetic cannabis products.
See also
JWH-030 JWH-307
Text derived from https://en.wikipedia.org/w/index.php?oldid=1373290897 under CC BY-SA 4.0; modifications have been made.